(Q34132786)

English

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications (English)

1 reference

Europe PubMed Central

31 July 2017

1 reference

based on heuristic

inferred from title

object named as

Luca Morandi

13

0 references

Enrico Franceschi

object named as

Enrico Franceschi

2

0 references

Gianluca Marucci

object named as

Gianluca Marucci

11

0 references

Alba A. Brandes

object named as

Alba A Brandes

1

0 references

10

object named as

Miran Skrap

1 reference

Europe PubMed Central

31 July 2017

author name string

Alicia Tosoni

3

1 reference

Europe PubMed Central

31 July 2017

Stefania Bartolini

4

1 reference

Europe PubMed Central

31 July 2017

Antonella Bacci

5

1 reference

Europe PubMed Central

31 July 2017

Raffaele Agati

6

1 reference

Europe PubMed Central

31 July 2017

Claudio Ghimenton

7

1 reference

Europe PubMed Central

31 July 2017

Sergio Turazzi

8

1 reference

Europe PubMed Central

31 July 2017

Andrea Talacchi

9

1 reference

Europe PubMed Central

31 July 2017

Lorenzo Volpin

12

1 reference

Europe PubMed Central

31 July 2017

Stefano Pizzolitto

14

1 reference

Europe PubMed Central

31 July 2017

Marina Gardiman

15

1 reference

Europe PubMed Central

31 July 2017

Alvaro Andreoli

16

1 reference

Europe PubMed Central

31 July 2017

Fabio Calbucci

17

1 reference

Europe PubMed Central

31 July 2017

Mario Ermani

18

1 reference

Europe PubMed Central

31 July 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

12

1 reference

Europe PubMed Central

31 July 2017

3

1 reference

Europe PubMed Central

31 July 2017

283-288

1 reference

Europe PubMed Central

31 July 2017

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

5 July 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

5 July 2018

Temozolomide preferentially depletes cancer stem cells in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

5 July 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

5 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

5 July 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOP050

21 January 2018

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOP050

21 January 2018

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOP050

21 January 2018

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOP050

21 January 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940594

28 October 2018

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

https://pubmed.ncbi.nlm.nih.gov/20167816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20167816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NEUONC/NOP050

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34132786&oldid=1971108277"